The Boards of AABB, APBMT, ASFA, ASTCT, NMDP, EBMT, EMBMT, FACT, ICCBBA, ISBT, ISCT, JACIE, LABMT, WBMT, and WMDA issued an updated consensus statement in support of the use of ISBT 128 in the coding of hematopoietic progenitor cell and other therapeutic cell products. The Boards of the above organizations encourage cell therapy facilities to use ISBT 128 product coding and labeling. Please contact ICCBBA if you would like your society to be added to the list of supporting organizations.

Joint statement between:

• EBAA
• EBAANZ
• EEBA
• ICCBBA

This document is intended to help facilities and software developers design appropriate ISBT 128 labels for tissue products.

This document is intended to help facilities, label vendors, and software developers design appropriate ISBT 128 labels for cellular therapy products. Greater detail is given for labeling than that provided in the ISBT 128 Technical Specification.

This document is intended to help facilities, label vendors, and software developers design appropriate ISBT 128 labels for blood products.

This document is intended to help facilities and software developers design appropriate ISBT 128 labels for ocular tissue products. Greater detail is given for labeling than that provided in the ISBT 128 Technical Specification.